Fetal Tachycardia: Definition, Causes, and Assessment

Definition

Fetal tachycardia is defined as a baseline fetal heart rate exceeding 160 beats per minute and persisting for at least 10 minutes. 1

Maternal fever and intra‑uterine infection (chorioamnionitis) are the most frequent maternal causes of fetal tachycardia during labor. 1
Maternal medications, especially tocolytics and sympathomimetic agents, commonly induce fetal tachycardia. 1
Maternal anxiety can trigger fetal tachycardia through increased catecholamine release. 1
Maternal hyperthyroidism leads to sustained fetal tachycardia; thyroid function testing is recommended when other etiologies have been excluded. 1

Uteroplacental insufficiency causing fetal hypoxia is a critical cause that threatens fetal well‑being. 1
Fetal tachycardia may represent an early compensatory response to hypoxia, appearing before other abnormal heart‑rate patterns develop. 1

The key distinguishing feature is variability:
- Moderate variability (6–25 bpm) with tachycardia is reassuring and predicts the absence of fetal acidemia.
- Absent variability with tachycardia signals potential fetal acidemia and warrants expedited delivery. 1

Review maternal medications, focusing on tocolytics and sympathomimetics, as they are common precipitants. 1
Assess fetal heart‑rate variability on continuous monitoring to differentiate compensated from decompensated states. 1
Check maternal thyroid function if tachycardia persists after exclusion of other causes. 1

Fetal tachycardia is defined as a baseline fetal heart rate greater than 160 beats per minute (bpm) sustained for 10 minutes or longer, according to the American Academy of Family Physicians and NICHD consensus 2
The American Academy of Family Physicians and NICHD consensus define fetal tachycardia as a baseline FHR exceeding 160 bpm 2
Normal baseline FHR is defined as 110-160 bpm, as stated by the American Academy of Family Physicians 2, 3

During labor augmentation with oxytocin, fetal tachycardia (>160 bpm) should prompt immediate evaluation for maternal fever, infection, hyperthyroidism, or fetal hypoxia, as recommended by the American College of Obstetricians and Gynecologists, based on guidelines from Praxis Medical Insights 3
If tachycardia develops during augmentation, discontinue oxytocin immediately and implement general resuscitative measures, including left lateral positioning, oxygen administration, IV fluid bolus, and maternal vital sign assessment, as advised by the American College of Obstetricians and Gynecologists, based on guidelines from Praxis Medical Insights 3
The presence of moderate variability (6-25 bpm) with tachycardia is reassuring and predicts absence of fetal acidemia, whereas absent variability combined with tachycardia is concerning and may indicate fetal compromise, according to the American Academy of Family Physicians and Praxis Medical Insights 2, 3